Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.12967 | 46 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.08247 | 46 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.07067 | 46 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.90313 | 42 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.01776 | 46 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.20316 | 47 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.69711 | 60 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.22206 | 51 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.05417 | 46 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.06482 | 46 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.0389 | 45 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.95951 | 43 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.16167 | 49 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.07306 | 46 |